Satsuma Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Satsuma Pharmaceuticals's estimated annual revenue is currently $6M per year.
- Satsuma Pharmaceuticals's estimated revenue per employee is $241,200
Employee Data
- Satsuma Pharmaceuticals has 25 Employees.
- Satsuma Pharmaceuticals grew their employee count by 0% last year.
Satsuma Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | CFO | Reveal Email/Phone |
2 | VP and Head Operations | Reveal Email/Phone |
3 | SVP amd Head CMC | Reveal Email/Phone |
4 | Senior Director Operations | Reveal Email/Phone |
5 | Chief Commercial Officer | Reveal Email/Phone |
Satsuma Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 542 | -3% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1634 | -2% | N/A | N/A |
#10 | $10.5M | 48 | 12% | N/A | N/A |
What Is Satsuma Pharmaceuticals?
Satsuma Pharmaceuticals is focused on developing best-in-class products to address the unmet needs of migraine sufferers.
keywords:N/AN/A
Total Funding
25
Number of Employees
$6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Satsuma Pharmaceuticals News
2022-03-22 - Satsuma Pharmaceuticals Announces Abstracts Accepted for ...
Satsuma Pharmaceuticals Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2022 Annual Meeting ; Session: P13:...
2022-03-22 - Satsuma Pharmaceuticals Reports 2021 Full Year and Fourth ...
Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic product, STS101, for the acute treatment of...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.5M | 25 | -32% | N/A |
#2 | $6.4M | 25 | -26% | N/A |
#3 | $2.7M | 26 | -10% | $7M |
#4 | $10.9M | 26 | -42% | $499M |
#5 | $26.8M | 26 | -54% | $130M |